Immunotherapy with live bacterium improves response rate in malignant pleural mesothelioma

Immunotherapy with a live bacterium combined with chemotherapy demonstrated more than 90% disease control and 59% response rate in patients with malignant pleural mesothelioma (MPM), according to...